These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10727759)

  • 1. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature atherothrombotic cerebrovascular disease. A prospective cohort study.
    Vermeulen EG; Rauwerda JA; Erix P; de Jong SC; Twisk JW; Jakobs C; Witjes RJ; Stehouwer CD
    Neth J Med; 2000 Apr; 56(4):138-46. PubMed ID: 10727759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study.
    de Jong SC; Stehouwer CD; van den Berg M; Geurts TW; Bouter LM; Rauwerda JA
    J Intern Med; 1999 Jul; 246(1):87-96. PubMed ID: 10447230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.
    Vermeulen EG; Stehouwer CD; Twisk JW; van den Berg M; de Jong SC; Mackaay AJ; van Campen CM; Visser FC; Jakobs CA; Bulterjis EJ; Rauwerda JA
    Lancet; 2000 Feb; 355(9203):517-22. PubMed ID: 10683000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives.
    van der Griend R; Haas FJ; Biesma DH; Duran M; Meuwissen OJ; Banga JD
    Atherosclerosis; 1999 Mar; 143(1):177-83. PubMed ID: 10208493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.
    van den Berg M; Franken DG; Boers GH; Blom HJ; Jakobs C; Stehouwer CD; Rauwerda JA
    J Vasc Surg; 1994 Dec; 20(6):933-40. PubMed ID: 7990188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.
    Stehouwer DA
    Drugs Aging; 2000 Apr; 16(4):251-60. PubMed ID: 10874520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Obstetric problems followed by stroke].
    Lubbers MF; Aarnoudse JG; van Doormaal JJ
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):705-8. PubMed ID: 10347622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial.
    Vermeulen EG; Stehouwer CD; Valk J; van der Knaap M; van den Berg M; Twisk JW; Prevoo W; Rauwerda JA
    Eur J Clin Invest; 2004 Apr; 34(4):256-61. PubMed ID: 15086356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine--relevant for atherogenesis?
    Kircher T; Sinzinger H
    Wien Klin Wochenschr; 2000 Jun; 112(12):523-32. PubMed ID: 10953870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.
    de Jong SC; Stehouwer CD; van den Berg M; Kostense PJ; Alders D; Jakobs C; Pals G; Rauwerda JA
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1316-24. PubMed ID: 10323785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
    van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
    J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?
    Maron BA; Loscalzo J
    Curr Atheroscler Rep; 2007 Nov; 9(5):375-83. PubMed ID: 18001620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.
    Lolin YI; Sanderson JE; Cheng SK; Chan CF; Pang CP; Woo KS; Masarei JR
    Heart; 1996 Aug; 76(2):117-22. PubMed ID: 8795472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Homocysteine and cardiovascular risk].
    Lutteri L; Chapelle JP; Gielen J
    Rev Med Liege; 1999 Jun; 54(6):541-7. PubMed ID: 10446525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.
    Ducloux D; Aboubakr A; Motte G; Toubin G; Fournier V; Chalopin JM; Drüeke T; Massy ZA
    Nephrol Dial Transplant; 2002 May; 17(5):865-70. PubMed ID: 11981075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine and renal disease.
    van Guldener C; Robinson K
    Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.
    Van den Berg M; Boers GH; Franken DG; Blom HJ; Van Kamp GJ; Jakobs C; Rauwerda JA; Kluft C; Stehouwert CD
    Eur J Clin Invest; 1995 Mar; 25(3):176-81. PubMed ID: 7781664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinaemia and cardiovascular risk in female ovariectomized rats: role of folic acid and hormone replacement therapy.
    el-Swefy SE; Ali SI; Asker ME; Mohamed HE
    J Pharm Pharmacol; 2002 Mar; 54(3):391-7. PubMed ID: 11902805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure.
    McGregor DO; Dellow WJ; Robson RA; Lever M; George PM; Chambers ST
    Kidney Int; 2002 Mar; 61(3):1040-6. PubMed ID: 11849459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.